Alkermes (ALKS) Share-based Compensation (2010 - 2026)

Alkermes' (ALKS) quarterly Share-based Compensation came in at $23.4 million in Q1 2026, down 20.61% year-on-year from $29.5 million in Q1 2025, and down 10.78% on a QoQ basis from $26.3 million in Q4 2025.

Alkermes (ALKS) Share-based Compensation (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has 17 years of Share-based Compensation data on file, last reported at $23.4 million in Q1 2026.

  • On a quarterly basis, Share-based Compensation fell 20.61% year-over-year to $23.4 million in Q1 2026; TTM through Mar 2026 was $52.4 million, a 37.95% increase from a year earlier, with the FY2025 full-year figure at $98.7 million, up 205.62% from the prior year.
  • Share-based Compensation for Q1 2026 stood at $23.4 million, down from $26.3 million in the prior quarter.
  • Over the last five years, Share-based Compensation for ALKS reached as high as $74.8 million in Q4 2023 and fell as low as $344000.0 in Q4 2024.
  • Historically, Share-based Compensation has averaged $15.3 million across 5 years, with a median of $9.1 million in 2023.
  • Across the five-year window, Share-based Compensation sank 99.54% in 2024 and soared 7538.08% in 2025, its largest moves.
  • Year by year, Share-based Compensation stood at $3.3 million in 2022, then soared by 2167.42% to $74.8 million in 2023, then sank by 99.54% to $344000.0 in 2024, then surged by 7538.08% to $26.3 million in 2025, then dropped by 10.78% to $23.4 million in 2026.
  • Per Business Quant data, the three most recent Share-based Compensation figures were $23.4 million in Q1 2026, $26.3 million in Q4 2025, and $622000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 43.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 25.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 125.69 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 58.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 56.50 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 55.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 21.00 Mn
10 Alkermes 9.72 Bn 9.21 Bn 331.33 Mn 23.44 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 23.44 Mn
Mar 31, 2026 23.44 Mn
Dec 31, 2025 26.28 Mn
Dec 31, 2025 26.28 Mn
Sep 30, 2025 622,000.00
Sep 30, 2025 622,000.00
Jun 30, 2025 2.08 Mn
Jun 30, 2025 2.08 Mn
Mar 31, 2025 29.53 Mn
Mar 31, 2025 29.53 Mn
Dec 31, 2024 344,000.00
Dec 31, 2024 344,000.00
Sep 30, 2024 5.52 Mn
Sep 30, 2024 5.52 Mn
Jun 30, 2024 2.61 Mn
Jun 30, 2024 2.61 Mn
Mar 31, 2024 11.23 Mn
Mar 31, 2024 11.23 Mn
Dec 31, 2023 74.83 Mn
Dec 31, 2023 74.83 Mn